A specific protein-enriched enteral formula decreases cortisolemia and improves plasma albumin and amino acid concentrations in elderly patients

Table 6 Insulin resistance and inflammatory biomarker concentrations at baseline and at 3 and 6 month in elderly patients exclusively receiving a protein-enriched enteral diet

	0 mo	3 mo	6 mo	P*
Insulin (mU/L)	3.12 ± 0.65^†	6.30 ± 1.32	4.62 ± 0.99	0.066
HOMA-IR	0.65 ± 0.13	1.41 ± 0.31	0.95 ± 0.20	0.087
Adiponectin (mg/mL)	18.7 ± 1.5	19.0 ± 1.6	20.3 ± 2.3	0.926
C-reactive protein (mg/L)	1.26 ± 0.44	1.58 ± 0.58	0.91 ± 0.28	0.886
Interleukin 6 (ng/L)	20.65 ± 4.10	29.36 ± 8.45	17.69 ± 6.29	0.424
Tumor Necrosis Factor alpha (ng/L)	4.28 ± 0.44^{a ‡}	4.53 ± 0.44^a	5.42 ± 0.46^b	0.007
Interleukin 8 (ng/L)	6.35 ± 0.94	6.62 ± 1.88	5.38 ± 1.39	0.165

HOMA-IR, homeostasis model assessment for insulin resistance.
* Differences between times were analyzed using the Friedman test, considering P < 0.05 to be significant.
^†x ± SEM (for all values).
Differences between times were analyzed using the Wilcoxon test, considering P < 0.05 to be significant. In each group, mean values within the same row with unlike superscript letters were significantly different.

ISSN: 1743-7075